Lucinactant - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for lucinactant and what is the scope of patent protection?
Lucinactant
is the generic ingredient in one branded drug marketed by Lees Pharm Hk and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for lucinactant
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 9 |
DailyMed Link: | lucinactant at DailyMed |
Recent Clinical Trials for lucinactant
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
Cystic Fibrosis Foundation Therapeutics | Phase 2 |
Cystic Fibrosis Foundation | Phase 2 |
US Patents and Regulatory Information for lucinactant
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lees Pharm Hk | SURFAXIN | lucinactant | SUSPENSION;INTRATRACHEAL | 021746-001 | Mar 6, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for lucinactant
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lees Pharm Hk | SURFAXIN | lucinactant | SUSPENSION;INTRATRACHEAL | 021746-001 | Mar 6, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |